Medtronic, Inc. (MDT) PT Raised to $94 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Medtronic, Inc. (MDT) PT Raised to $99 at Jefferies; Q2 Eases Growth Concerns
November 22, 2017 7:45 AM ESTJefferies raised its price target on Medtronic, Inc. (NYSE: MDT) to $99.00 (from $96.00) while maintaining a Buy rating following Q2 results.
Analyst Raj Denhoy said the results eased concerns of a slowing growth trajectory.
"Despite weather impacts, F18 guidance for +4-5% sales and... More
Medtronic, Inc. (MDT) PT Raised to $86 at Wells Fargo on 2Q Report; 'Better gross Margin Than Modeled'
November 22, 2017 7:28 AM ESTWells Fargo raised its price target on Medtronic, Inc. (NYSE: MDT) to $86.00 (from $83.00) while maintaining a Market Perform rating, following the company's second quarter earnings report.
Analyst Larry Biegelsen notes a positive outlook on the shares, as the company reported second quarter... More
Medtronic, Inc. (MDT) PT Raised to $88 at Leerink Partners, Gorwth Should Accelerate in H2 2018
November 22, 2017 7:15 AM ESTLeerink Partners raised its price target on Medtronic, Inc. (NYSE: MDT) to $88.00 (from $85.00) while maintaining a Market Perform rating.
... MoreMedtronic, Inc. (MDT) PT Raised to $85 at Stifel
November 22, 2017 6:52 AM ESTStifel raised its price target on Medtronic, Inc. (NYSE: MDT) to $85.00 (from $83.00) while maintaining a Hold rating.
... MoreMedtronic, Inc. (MDT) PT Bumped to $95 at Needham & Company
November 21, 2017 3:46 PM ESTNeedham & Company analyst Mike Matson bumped his price target on Medtronic, Inc. (NYSE: MDT) to $95.00 (from $94.00) while maintaining a Buy rating following Q1 results that beat the Street and reiterated guidance.
Matson notes organic revenue growth improved to 4.0% (excluding Hurricane Maria)... More
Medtronic (MDT) Tops Q2 EPS by 8c, Reiterates Guidance
November 21, 2017 6:48 AM ESTMedtronic (NYSE: MDT) reported Q2 EPS of $1.07, $0.08 better than the analyst estimate of $0.99. Revenue for the quarter came in at $7.1 billion versus the consensus estimate of $6.93 billion.
Guidance
Medtronic today reiterated its revenue and non-GAAP EPS guidance. The company's guidance is given on a comparable, constant currency basis, which accounts for the divestiture of certain businesses from its prior period Patient Monitoring & Recovery division by removing the financial impact... More
